US Broker Ratings

Innoviva, Inc. (INVA) Stock Analysis: Uncovering a Potential 182% Upside in the Biotech Sector

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the biotechnology sector, is currently capturing the attention of investors with a remarkable potential upside of 182%. As..

Phreesia, Inc. (PHR) Stock Analysis: A 19% Potential Upside in Healthcare SaaS

Phreesia, Inc. (PHR), a prominent player in the healthcare information services sector, has been making waves with its robust growth metrics and promising analyst projections. Specializing..

Mesoblast Limited (MESO) Stock Analysis: Unveiling an 84% Potential Upside for Investors

Mesoblast Limited (NASDAQ: MESO), a pioneering biotech company in the healthcare sector, is capturing investor attention with its promising regenerative medicine platform. Headquartered in Melbourne, Australia,..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Exploring a 31% Potential Upside in the Biotech Sector

PTC Therapeutics, Inc. (NASDAQ: PTCT) stands out in the biotechnology industry with its commitment to developing innovative treatments for rare disorders. Headquartered in Warren, New Jersey,..

Kymera Therapeutics (KYMR) Stock Analysis: Impressive Revenue Growth and Strong Buy Ratings Signal Potential Upside

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biotechnology firm at the cutting edge of therapeutic development, is captivating the attention of investors with its promising portfolio and..

Artivion, Inc. (AORT) Stock Analysis: A Strong Buy Rating with a 6.77% Upside Potential

Artivion, Inc. (NASDAQ: AORT), a key player in the healthcare sector, particularly within the medical devices industry, is capturing investor attention with a notable market cap..

Apellis Pharmaceuticals (APLS) Stock Analysis: A Biotech Powerhouse with 83% Upside Potential

For investors with an eye on the biotechnology sector, Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) presents a compelling opportunity. With a market capitalization of $2.42 billion, this..

Neogen Corporation (NEOG) Stock Analysis: Unveiling a 56.9% Potential Upside for Investors

Neogen Corporation (NASDAQ: NEOG), a key player in the healthcare sector specializing in diagnostics and research, offers a compelling investment opportunity with a notable potential upside..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Unpacking the 320.97% Potential Upside and Strong Analyst Confidence

Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage biopharmaceutical company, is making waves in the healthcare sector with its ambitious pipeline targeting chronic diseases. With a market..

Vericel Corporation (VCEL) Stock Analysis: Unveiling a 63.92% Potential Upside in the Biotech Sector

Vericel Corporation (NASDAQ: VCEL) has been making waves in the biotechnology sector, appealing to investors with its innovative approach to cellular therapies and specialty biologics. As..

National HealthCare Corporation (NHC) Stock Analysis: Evaluating the 25.7% Revenue Growth in the Healthcare Sector

As the U.S. healthcare industry continues to navigate the complexities of an aging population and evolving medical needs, National HealthCare Corporation (NHC) emerges as a key..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: A 42.68% Potential Upside Opportunity in the Healthcare Sector

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) is capturing the attention of investors seeking opportunities in the healthcare sector. With a potential upside of 42.68%, as indicated..

Premier, Inc. (PINC) Stock Analysis: Navigating Healthcare with a 4.01% Dividend Yield

Premier, Inc. (NASDAQ: PINC), a formidable player in the health information services industry, continues to capture investor attention with its strategic operations in healthcare improvement. Headquartered..

CG Oncology, Inc. (CGON) Stock Analysis: A Biotech Contender with a 124% Upside Potential

Investors with an eye on the biotechnology sector might find CG Oncology, Inc. (NASDAQ: CGON) an intriguing candidate, primarily due to its substantial growth potential. With..

Azenta, Inc. (AZTA) Stock Analysis: Navigating a 2.97% Upside in the Medical Instruments Sector

For investors eyeing opportunities in the healthcare sector, Azenta, Inc. (NASDAQ: AZTA) presents a compelling case, especially given its strategic positioning in the medical instruments and..

Immunocore Holdings plc (IMCR) Stock Analysis: 68% Potential Upside Draws Investor Attention

Immunocore Holdings plc (NASDAQ: IMCR), a trailblazer in the biotechnology sector, commands investor interest with a compelling potential upside of 68.37%. Specializing in immunotherapies for cancer,..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: A Biotech with 189.90% Potential Upside

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a promising player in the biotechnology industry, is capturing investor attention with its robust pipeline and a staggering potential upside of..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring a 65% Potential Upside in the Healthcare Sector

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) has been making waves in the healthcare sector, specifically within the niche of medical instruments and supplies. Based in Kirkland,..

CONMED Corporation (CNMD) Stock Analysis: Eyeing a 39% Potential Upside in the Medical Device Market

For investors with an interest in the healthcare sector, particularly medical devices, CONMED Corporation (NASDAQ: CNMD) presents a compelling proposition. The company, with a market capitalization..

Adaptive Biotechnologies Corp (ADPT) Stock Analysis: A 15% Upside Potential in the Biotech Sector

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a key player in the biotechnology sector, is attracting investor attention with its promising growth potential and strategic collaborations. Headquartered in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds